Cerebrolysin

 Cerebrolysin

Primary Function: Neuroregeneration, cognitive enhancement, and neuroprotection
Research Use: Stroke recovery, neurodegenerative diseases, traumatic brain injury (TBI), memory improvement
Composition: A peptide mixture derived from purified porcine brain proteins
Synonyms: Cere, Cebrolysin, Cerebrolysate

Description:
Cerebrolysin is a neurotrophic peptide complex composed of low molecular weight peptides and amino acids derived from porcine brain tissue. It is widely studied for its potential to repair neuronal structures, enhance cognitive function, and protect against neurodegeneration. Its multifactorial mechanism makes it a powerful candidate for research in Alzheimer’s disease, stroke recovery, TBI, and age-related cognitive decline.

Mechanism of Action:

• Mimics endogenous neurotrophic factors such as BDNF and NGF
• Stimulates neuronal growth, differentiation, and synaptic plasticity
• Reduces excitotoxicity and oxidative stress
• Inhibits apoptosis and supports mitochondrial function

Key Research Areas:

• Alzheimer’s disease and dementia models
• Stroke and ischemic injury recovery
• Parkinson’s and neurodegenerative conditions
• Age-related memory and cognitive enhancement

History of Discovery:
Cerebrolysin was developed in Austria by EVER Pharma in the 1970s and has since been used in over 50 countries for clinical research and therapeutic protocols. It is one of the few peptide-based compounds shown to have both neuroprotective and neurotrophic effects, making it unique among nootropic and neurorepair agents.

Case Studies:

1. Stroke Recovery (2005, Stroke Journal): In a randomized clinical trial, patients receiving Cerebrolysin showed significantly improved functional outcomes post-ischemic stroke. [Stroke. 2005;36(5):1116–1122.]
2. Alzheimer’s Disease (2013, J Neural Transm): Cerebrolysin improved global function and cognition scores in mild-to-moderate Alzheimer’s patients over 24 weeks. [J Neural Transm. 2013;120(1):145–149.]
3. Traumatic Brain Injury (2011, Brain Inj): TBI patients treated with Cerebrolysin demonstrated enhanced neurological recovery and faster rehabilitation timelines. [Brain Inj. 2011;25(2):122–134.]

Packaging Information:

• Form: Sterile solution or lyophilized powder
• Purity: Pharmaceutical-grade peptide blend
• Storage: Store at 2–8°C (refrigerated)
• For research use only. Not for human or veterinary use.